FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078647570> ?p ?o ?g. }

• W2078647570 endingPage "61" @default.
• W2078647570 startingPage "53" @default.
• W2078647570 abstract "Molecularly targeted therapies have transformed the management of PML-RARA+ acute promyelocytic leukaemia (APL), with survival rates now exceeding 80% in clinical trials. This raises questions about the relevance of post-remission monitoring for PML-RARA transcripts, which has been widely used to predict relapse, guiding early intervention to prevent disease progression and the inherent risk of fatal bleeding. Given the treatability of haematological relapse, survival benefits would only be seen if monitoring could identify patients who could be salvaged if treated early but not later on, although it could be argued that early deployment of arsenic trioxide (ATO) can avoid inducing hyperleucocytosis and the associated differentiation syndrome, which frequently complicate treatment of frank relapse. However, given the low rates of relapse now observed in patients presenting with standard risk disease (i.e. presenting WBC <10 × 109/l) who achieve early molecular remission, subsequent sequential minimal residual disease (MRD) monitoring confers only a marginal benefit, so could be avoided in this group. However, sequential MRD monitoring may still be of value in patients with high risk APL, although evidence tends to come from historically controlled studies. Therefore, there may remain a role for MRD monitoring in the most clinically challenging subsets of APL, but the continuing debate highlights the need for robust evidence in developing a more individualized approach to management of other subtypes of acute leukaemia." @default.
• W2078647570 created "2016-06-24" @default.
• W2078647570 creator A5009449067 @default.
• W2078647570 creator A5046387225 @default.
• W2078647570 creator A5089075443 @default.
• W2078647570 date "2014-03-01" @default.
• W2078647570 modified "2023-10-18" @default.
• W2078647570 title "Can we say farewell to monitoring minimal residual disease in acute promyelocytic leukaemia?" @default.
• W2078647570 cites W1534823462 @default.
• W2078647570 cites W1577763442 @default.
• W2078647570 cites W1790757523 @default.
• W2078647570 cites W1965141571 @default.
• W2078647570 cites W1987176851 @default.
• W2078647570 cites W1992842669 @default.
• W2078647570 cites W1996468867 @default.
• W2078647570 cites W1996652585 @default.
• W2078647570 cites W1996750522 @default.
• W2078647570 cites W2031219597 @default.
• W2078647570 cites W2036862498 @default.
• W2078647570 cites W2039340233 @default.
• W2078647570 cites W2047011631 @default.
• W2078647570 cites W2052246089 @default.
• W2078647570 cites W2060038105 @default.
• W2078647570 cites W2075957152 @default.
• W2078647570 cites W2078054197 @default.
• W2078647570 cites W2090912148 @default.
• W2078647570 cites W2102362614 @default.
• W2078647570 cites W2129338773 @default.
• W2078647570 cites W2135898904 @default.
• W2078647570 cites W2135938821 @default.
• W2078647570 cites W2159507916 @default.
• W2078647570 cites W2166981346 @default.
• W2078647570 cites W2169046713 @default.
• W2078647570 cites W4376595466 @default.
• W2078647570 cites W45100087 @default.
• W2078647570 doi "https://doi.org/10.1016/j.beha.2014.04.002" @default.
• W2078647570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24907017" @default.
• W2078647570 hasPublicationYear "2014" @default.
• W2078647570 type Work @default.
• W2078647570 sameAs 2078647570 @default.
• W2078647570 citedByCount "24" @default.
• W2078647570 countsByYear W20786475702014 @default.
• W2078647570 countsByYear W20786475702015 @default.
• W2078647570 countsByYear W20786475702016 @default.
• W2078647570 countsByYear W20786475702017 @default.
• W2078647570 countsByYear W20786475702018 @default.
• W2078647570 countsByYear W20786475702019 @default.
• W2078647570 countsByYear W20786475702020 @default.
• W2078647570 countsByYear W20786475702021 @default.
• W2078647570 crossrefType "journal-article" @default.
• W2078647570 hasAuthorship W2078647570A5009449067 @default.
• W2078647570 hasAuthorship W2078647570A5046387225 @default.
• W2078647570 hasAuthorship W2078647570A5089075443 @default.
• W2078647570 hasConcept C104317684 @default.
• W2078647570 hasConcept C118552586 @default.
• W2078647570 hasConcept C126322002 @default.
• W2078647570 hasConcept C143998085 @default.
• W2078647570 hasConcept C177713679 @default.
• W2078647570 hasConcept C185592680 @default.
• W2078647570 hasConcept C187212893 @default.
• W2078647570 hasConcept C190283241 @default.
• W2078647570 hasConcept C2776601000 @default.
• W2078647570 hasConcept C2778461978 @default.
• W2078647570 hasConcept C2779134260 @default.
• W2078647570 hasConcept C2779823535 @default.
• W2078647570 hasConcept C2780386689 @default.
• W2078647570 hasConcept C2780665704 @default.
• W2078647570 hasConcept C2781121885 @default.
• W2078647570 hasConcept C535046627 @default.
• W2078647570 hasConcept C55493867 @default.
• W2078647570 hasConcept C71924100 @default.
• W2078647570 hasConceptScore W2078647570C104317684 @default.
• W2078647570 hasConceptScore W2078647570C118552586 @default.
• W2078647570 hasConceptScore W2078647570C126322002 @default.
• W2078647570 hasConceptScore W2078647570C143998085 @default.
• W2078647570 hasConceptScore W2078647570C177713679 @default.
• W2078647570 hasConceptScore W2078647570C185592680 @default.
• W2078647570 hasConceptScore W2078647570C187212893 @default.
• W2078647570 hasConceptScore W2078647570C190283241 @default.
• W2078647570 hasConceptScore W2078647570C2776601000 @default.
• W2078647570 hasConceptScore W2078647570C2778461978 @default.
• W2078647570 hasConceptScore W2078647570C2779134260 @default.
• W2078647570 hasConceptScore W2078647570C2779823535 @default.
• W2078647570 hasConceptScore W2078647570C2780386689 @default.
• W2078647570 hasConceptScore W2078647570C2780665704 @default.
• W2078647570 hasConceptScore W2078647570C2781121885 @default.
• W2078647570 hasConceptScore W2078647570C535046627 @default.
• W2078647570 hasConceptScore W2078647570C55493867 @default.
• W2078647570 hasConceptScore W2078647570C71924100 @default.
• W2078647570 hasIssue "1" @default.
• W2078647570 hasLocation W20786475701 @default.
• W2078647570 hasLocation W20786475702 @default.
• W2078647570 hasOpenAccess W2078647570 @default.
• W2078647570 hasPrimaryLocation W20786475701 @default.
• W2078647570 hasRelatedWork W2013520247 @default.
• W2078647570 hasRelatedWork W2080952699 @default.
• W2078647570 hasRelatedWork W2090387747 @default.
• W2078647570 hasRelatedWork W2178253779 @default.

• next